Adult acute megakaryoblastic leukemia: rare association with cytopenias of undetermined significance and p210 and p190 BCR–ABL transcripts
Open Access
- 1 October 2017
- journal article
- case report
- Published by Taylor & Francis in OncoTargets and Therapy
- Vol. ume 10, 5047-5051
Abstract
Acute megakaryocytic leukemia (M7-AML) is a rare form of acute myeloid leukemia (AML), which is associated with poor prognosis. The case presented in the current report is a statement for the difficult diagnosis and clinical management of M7-AML in the context of a previous hematologic disorder of undetermined significance and associated genetic abnormalities. Probably, following the complete hematologic remission and further with induction chemotherapy plus tyrosine kinase inhibitor therapy, the clinical management of this case will be followed by a allogeneic bone marrow transplantation, the only proven therapy to improve overall survival.Keywords
This publication has 17 references indexed in Scilit:
- The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemiaBlood, 2016
- Acute megakaryocytic leukemia is associated with worse outcomes than other types of acute myeloid leukemiaBlood, 2014
- Dasatinib induces complete hematologic and cytogenetic responses in patients with imatinib-resistant or -intolerant chronic myeloid leukemia in blast crisisBlood, 2006
- e6a2 BCR-ABL transcript in chronic myeloid leukemia: is it associated with aggressive disease?2004
- FLAG-IDA in the treatment of refractory/relapsed acute myeloid leukemia: single-center experienceAnnals of Hematology, 2003
- Acute Megakaryoblastic Leukaemia: A National Clinical and Biological Study of 53 Adult and Childhood Cases by the Groupe Français d'Hématologie Cellulaire (GFHC)Leukemia & Lymphoma, 2003
- Acute megakaryoblastic leukemia: experience of GIMEMA trialsLeukemia, 2002
- Acute megakaryocytic leukemia: the Eastern Cooperative Oncology Group experience.2000
- Cytarabine plus idarubicin or daunorubicin as induction and consolidation therapy for previously untreated adult patients with acute myeloid leukemia.1992
- Criteria for the Diagnosis of Acute Leukemia of Megakaryocyte Lineage (M7)Annals of Internal Medicine, 1985